CLINICAL TRIALS PROFILE FOR LOXITANE C
✉ Email this page to a colleague
All Clinical Trials for LOXITANE C
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00648778 ↗ | Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2003-01-01 | The objective of this study was to investigate the bioequivalence of Mylan loxapine succinate 25 mg capsules to Watson Loxitane 25 mg capsules following a single, oral 25 mg (1 x 25 mg) dose administration under fasting conditions. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LOXITANE C
Condition Name
Clinical Trial Locations for LOXITANE C
Trials by Country
Clinical Trial Progress for LOXITANE C
Clinical Trial Phase
Clinical Trial Sponsors for LOXITANE C
Sponsor Name